Skip Ribbon Commands
Skip to main content


HIV infection and HIV-associated behaviors among persons who inject drugs – 20 cities, United States, 2015


JC Burnett, D Broz, MW Spiller, et al

Network Affiliation




Journal Name

MMWR Morb Mortal Wkly Rep.

Publication Date


PubMed Search

Link to full-text





In  the United States, 9% of human immunodeficiency virus (HIV) infections diagnosed in 2015 were attributed to injection drug use (1). In 2015, 79% of diagnoses of HIV infection among persons who inject drugs occurred in urban areas (2). To monitor the prevalence of HIV infection and associated behaviors among persons who inject drugs, CDC's National HIV Behavioral Surveillance (NHBS) conducts interviews and HIV testing in selected metropolitan statistical areas (MSAs) (3). The prevalence of HIV infection among persons who inject drugs in 20 MSAs in 2015 was 7%. In a behavioral analysis of HIV-negative persons who inject drugs, an estimated 27% receptively shared syringes and 67% had condomless vaginal sex in the previous 12 months. During the same period, 58% had tested for HIV infection and 52% received syringes from a syringe services program. Given the increased number of persons newly injecting drugs who are at risk for HIV infection because of the recent opioid epidemic (2,4), these findings underscore the importance of continuing and expanding health services, HIV prevention programs, and community-based strategies, such as those provided by syringe services programs, for this population.




Behavior; Substance Abuse


Created at 1/25/2018 10:32 AM by Davis, Gregory P
Last modified at 1/25/2018 10:32 AM by Davis, Gregory P